Clinical trial · Observational
Intraoperative Adverse Events in Robotic Radical Gastrectomy for Gastric Cancer
Appraisal of Surgical Outcomes and Oncological Efficiency of Intraoperative Adverse Events in Robotic Radical Gastrectomy for Gastric Cancer
NCT05999019CI-TRIAL-00068958completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Surgical quality control is a crucial determinant of evaluating the tumor efficacy. We assess the ClassIntra grade for quality control and oncological outcomes of robotic radical surgery for gastric cancer (GC).
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Gastric Cancer | Malignant Gastric Neoplasm | CURATED_BROADER | 0.80 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| robotic surgery | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (1)
- measure
- ClassIntra grade
- timeFrame
- 1 months
- description
- Patients who experienced iAE were classified into the iAE group using ClassIntra grading (version 1.0). The iAEs were further classified into five sublevels (ranging from I to V according to severity) based on the ClassIntra grade
Secondary outcomes (3)
- measure
- Objective Structured Assessment of Technical Skill (OSATS)
- timeFrame
- 1 months
- description
- Surgical performance was assessed using the Objective Structured Assessment of Technical Skill (OSATS)
- measure
- 3-year overall survival
- timeFrame
- 36 months
- description
- Overall survival (OS) was calculated from the date of surgery to death from any cause or the last follow-up.
Eligibility
Eligibility (as posted)
- Sex
- All
Show eligibility criteria text
Inclusion Criteria: * Patients diagnosed with gastric adenocarcinoma through pathology; * Preoperative chest radiograph, abdominal ultrasonogram, and full abdominal CT examination showed no distant metastasis to the liver, lungs, or abdominal cavity; * Patients who underwent robotic radical gastrectomy. Exclusion Criteria: * Intraoperatively existing distant metastases * Neoadjuvant chemotherapy * Missing general and video data.
References
Publications (0)
Data not yet available
No reference posted for this study.